Double-Blind Controlled Randomized Trial of Cyclophosphamide versus Methylprednisolone in Secondary Progressive Multiple Sclerosis

BACKGROUND: Therapeutic options are limited in secondary progressive multiple sclerosis (SPMS). Open-label studies suggested efficacy of monthly IV cyclophosphamide (CPM) without induction for delaying progression but no randomized trial was conducted so far. OBJECTIVE: To compare CPM to methylpredn...

Descripción completa

Detalles Bibliográficos
Autores principales: Brochet, Bruno, Deloire, Mathilde S. A., Perez, Paul, Loock, Timothé, Baschet, Louise, Debouverie, Marc, Pittion, Sophie, Ouallet, Jean-Christophe, Clavelou, Pierre, de Sèze, Jérôme, Collongues, Nicolas, Vermersch, Patrick, Zéphir, Hélène, Castelnovo, Giovanni, Labauge, Pierre, Lebrun, Christine, Cohen, Mikael, Ruet, Aurélie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5207788/
https://www.ncbi.nlm.nih.gov/pubmed/28045953
http://dx.doi.org/10.1371/journal.pone.0168834

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5207788/
https://www.ncbi.nlm.nih.gov/pubmed/28045953
http://dx.doi.org/10.1371/journal.pone.0168834

Ejemplares similares